Next-gen ultrasound cancer treatment advances: does the evidence match commercial hype?
Hong Kong is expanding clinical trials of histotripsy, a non-invasive treatment that uses focused ultrasound to destroy tumours, as the city seeks to establish a role in developing the technology for kidney cancer. The CUHK Medical...
Lean: Leans right
Fact-focusedFactuality: HighCountry: Hong KongFunding: CorporateOwner: Alibaba Group
Coverage breakdown
Funding
Corporate100%
Countries
Hong Kong100%
Media ownership
Alibaba Group100%
Avg reliability75
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 41 (Limited corroboration)
Propaganda risk: 0
Trending: Low
Sources: 1
Reliability: 75
Bias severity: 0
Risk: 0Sentiment: 0Sensationalism: 6
Amplification: 0
